GSK (GSK) continued losses for a seventh straight session as the stock closed xx% lower, at $xx on Friday. The British ...

Haleon was spun off from GSK amid investor pressure, showing steady growth but facing debt concerns. See more about HLN stock ...

A new vaccines drug substance facility and R&D pilot plant, completed by the end of 2028, will create over 200 new jobs.

The British pharma is making what it calls its largest U.S. manufacturing investment. Elsewhere, AbbVie expanded a ...

After making a splash in the U.K. earlier this year, GSK is laying out plans for its biggest U.S. manufacturing investment ...

A global biopharma company just announced that it will be investing up to $800 million to expand its long-time Lancaster ...

GSK plans to invest $800 million in its East Donegal Township vaccine packaging facility over the next four years in an ...

Shares of GSK PLC GSK inched up 0.52% to £14.56 Thursday, on what proved to be an all-around positive trading session for the ...

British drugmaker GlaxoSmithKline sued Moderna in U.S. federal court in Delaware on Tuesday, accusing it of violating GSK ...

Shares of GSK PLC GSK inched down 0.72% to £14.54 Tuesday, on what proved to be an all-around dismal trading session for the ...

GSK Plc’s experimental drug to treat a common inflammatory nasal condition showed positive results in two late-stage trials ...

GSK has announced a new collaboration with local university and medical researchers, while Editas Medicine has a deal to ...